Modification of methodology results in improvement in simultaneous kidney-islet success.
Brennan
D C
DC
Islet Transplant Center, Washington University School of Medicine, St Louis, MO 63110.
Scharp
D W
DW
White
N H
NH
Flavin
K S
KS
Zukosky
J M
JM
Ansara
M F
MF
Cryer
P E
PE
Lacy
P E
PE
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002096:C-Peptide / Q000097:blood; D002478:Cells, Cultured; D016572:Cyclosporine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007515:Islets of Langerhans; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000379:methods* / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology / Q000379:methods* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D014021:Tissue Preservation; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D002096:C-Peptide; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone